The European Partnership for Personalized Medicine (EP PerMed) partnership launched in January 2024. More than 50 partners and financing organisations from different EU countries are involved in the partnership. In Finland, Business Finland participates as a funding partner. In November 2025, a new joint transnational call 2026 (JTC2026) "Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases" (acronym: CARMEN2026). The call is co-funded by the European Union. The preliminary budget for the call is approximately EUR 38 million. Business Finland has a grant budget of EUR 1 million for Finnish participants.
Aim of the Call
See JTC2026 call text for detailed description of the call. With this JTC, EP PerMed will fund research projects in human health on innovative PM strategies for patients with cardiovascular, metabolic or kidney diseases. Research projects may focus on a single disease or explore these conditions in combination. Proposals should address one or more of the following aspects:
- Innovative personalised therapeutic approaches;
- Monitoring of treatment response in patients in order to tailor treatment pathways;
- Early disease risk prediction and prevention of disease worsening or comorbidities.
Consortium
Consortia are required to be international, interdisciplinary and cross-sector. See JTC2026 call text for detailed requirements.
In addition to the JTC2026 criteria, applicant organizations and projects must meet Business Finland's funding criteria, which are outlined in the funding terms and conditions as well as on Business Finland website. Business Finland uses grants to fund companies and research organizations in this call. Additionally, funding may be granted to a wellbeing services county or HUS (Helsinki University Hospital), provided that the same consortium includes a Finnish company as another applicant with its own project. According to the principles of the call, Business Finland can fund a maximum of two Finnish organizations per consortium, which is why certain exceptions to our standard criteria are applied (see below). We particularly encourage companies to participate in consortia. The results of public research must be broadly applicable to the business sector. Depending on the applicant organization, Business Finland will use its RD-funding, Co-Innovation, or Co-Research funding services.
Co-Innovation
- Learn more about funding and requirements: Co-Innovation. Exceptions: one Finnish research organization and one Finnish company with their own projects are sufficient to form a Co-Innovation consortium. Finnish consortia consisting of two Finnish companies are also treated as Co-Innovation applications. Note, that no single project may exceed 70% of the costs of the international joint project.
Wellbeing Services Counties/HUS
- Learn more about funding and requirements: Funding for university hospitals. Exceptions: a wellbeing services county/HUS and one Finnish company with their own projects are sufficient to form a Co-Innovation consortium.
Single Company RDI
- Learn more about funding and requirements: Research, development and piloting for SMEs and midcaps and Research, development and piloting for large companies.
Co-Research
- Learn more about funding and requirements: Co-Research. If two research organizations or one research organization without a Finnish company with its own project apply for funding, the Co-Research funding model is used. A requirement for funding is that at least 10% of the Finnish research organization’s budget must be funded by a company.
Preliminary schedule
This schedule is not updated after publication of the call. Possible updates to the schedule on the PerMed website.
The call is two-phased:
- Call launch 25.11.2025
- Deadline for pre-proposal submission 10.2.2026 at 14:00 CET
- Communication of the results of the pre-proposal assessment and invitation to the full-proposal stage (project coordinator) around early May 2026
- Deadline for full-proposal submission 9.6.2026
- Deadline for application for Business Finland 14.6.2026
- Rebuttal stage end of August 2026
- Communication of the decisions to the applicants October 2026
- Expected project start end of 2026/beginning of 2027
More information
Contact the Business Finland contact person before sending the pre-proposal applications.
Electronic pre-proposals and full proposals are submitted using the EP PerMed – submission portal. Finnish participants submit a separate application for Business Finland via Business Finland online services in the second phase of the call by 14.6.2026. Eligible applicants will be instructed after the first phase.
More information about the call and Business Finland requirements